Max Brosa-Riestra, F. Pérez-Alcántara, L. Borderías-Clau, Juan Bautista Galdiz-Iturri, Maribel Riera-Febrer, Montse Figueras-Sabaté
{"title":"Análisis de coste-utilidad de indacaterol frente a tiotropio en el tratamiento de la EPOC en España","authors":"Max Brosa-Riestra, F. Pérez-Alcántara, L. Borderías-Clau, Juan Bautista Galdiz-Iturri, Maribel Riera-Febrer, Montse Figueras-Sabaté","doi":"10.1007/S40277-013-0011-X","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"49 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PharmacoEconomics Spanish Research Articles","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/S40277-013-0011-X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
